Literature DB >> 17458794

[Does cataract surgery increase the risk of exudative age-related macular degeneration? Results from a large retrospective case-control study].

M Menghini1, F K Sutter, D Barthelmes, J C Fleischhauer, M M Kurz-Levin, M M Boesch, H Helbig.   

Abstract

BACKGROUND: Many epidemiological studies indicate a positive correlation between cataract surgery and the subsequent progression of age-related macular degeneration (AMD). Such a correlation would have far-reaching consequences. However, in epidemiological studies it is difficult to determine the significance of a single risk factor, such as cataract surgery. PATIENTS AND METHODS: We performed a retrospective case-control study of patients with new onset exudative age-related macular degeneration to determine if cataract surgery was a predisposing factor. A total of 1496 eyes were included in the study: 984 cases with new onset of exudative AMD and 512 control eyes with early signs of age-related maculopathy. Lens status (phakic or pseudophakic) was determined for each eye.
RESULTS: There was no significant difference in lens status between study and control group (227/984 [23.1 %] vs. 112/512 [21.8 %] pseudophakic, p = 0.6487; OR = 1.071; 95 % CI = 0.8284-1.384). In cases with bilateral pseudophakia (n = 64) no statistically significant difference of the interval between cataract surgery in either eye and the onset of exudative AMD in the study eye was found (225.9 +/- 170.4 vs. 209.9 +/- 158.2 weeks, p = 0.27).
CONCLUSIONS: Our results provide evidence that cataract surgery is not a major risk factor for the development of exudative AMD.

Entities:  

Mesh:

Year:  2007        PMID: 17458794     DOI: 10.1055/s-2007-962896

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  1 in total

1.  [Visual acuity after cataract surgery in patients with age-related macular degeneration].

Authors:  H Baatz; R Darawsha; G Scharioth; D De Ortueta; H Ackermann
Journal:  Ophthalmologe       Date:  2008-10       Impact factor: 1.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.